Exhaled Breath Samples May Offer Non-Invasive Insight into Lung Microbiome, Study Suggests
Researchers at the Medical University of Lodz have evaluated the feasibility of using exhaled breath condensate to analyze the lung microbiome in non-small cell lung cancer patients.
Key points
- Evaluated exhaled breath condensate as a non-invasive source for lung microbiome analysis in 32 NSCLC patients.
- Identified consistent bacterial signatures, including genera previously linked to lung malignancy, matching tumor tissue data.
- Study authors note that further research incorporating healthy control groups is strictly required before clinical application.
A recent study published in Scientific Reports by researchers from the Medical University of Lodz investigated whether exhaled breath condensate (EBC) can serve as a viable, non-invasive source for studying the pulmonary microbiome in patients with non-small cell lung cancer (NSCLC). Because early-stage lung cancer frequently presents with non-specific symptoms, identifying reliable, non-invasive diagnostic tools remains a critical objective in oncology research. Emerging evidence has linked shifts in the lung microbiome to the progression of NSCLC.
The research team conducted 16S rRNA gene metabarcoding on 32 EBC samples, comparing their microbial profiles directly against matched tumor tissues and adjacent control lung samples. According to the findings, EBC successfully yielded sufficient bacterial sequence data for microbiome profiling. Furthermore, the analysis showed that a detectable fraction of the EBC microbial signature originated from lung-tissue sources, with seven specific bacterial genera appearing across all examined sample types. Notably, the genus Escherichia-Shigella, which has previously been linked to lung malignancy, was consistently detected in the breath condensate. The authors also observed a higher bacterial sequence retention rate in EBC samples, indicating a potentially lower level of host DNA interference.
What to know: While these early findings suggest that exhaled breath could eventually support pulmonary microbiome research, the study represents a preliminary technical assessment. The authors emphasize that further investigations involving healthy control groups are necessary before EBC can be considered for clinical biomarker development. Always consult a qualified healthcare provider for personal medical advice or decisions.
Source Nature Health Sciences — nature.com/articles/s41598-026-79914-z ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…